Medicare Enrolled

Dr. Robert Trapp, MD

Rheumatology · Springfield, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
800 N 1ST ST, Springfield, IL 62702
2175287541
In practice since 2006 (19 years)
NPI: 1841363751 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Trapp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trapp? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Trapp

Dr. Robert Trapp is a rheumatology specialist in Springfield, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Trapp performed 13,890 Medicare services across 683 unique beneficiaries.

Between the years covered by Open Payments, Dr. Trapp received a total of $9,755 from 23 pharmaceutical and/or device companies across 341 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Trapp is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 32% volume in IL $9,755 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,890
Medicare services
Top 32% in IL for rheumatology
683
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~731 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
10,000 $11 $69
Denosumab injection (Prolia/Xgeva) 2,520 $19 $41
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
280 $6 $291
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
234 $54 $382
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
229 $90 $555
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
219 $6 $6
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
149 $44 $311
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
74 $21 $149
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
49 $10 $50
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
47 $89 $679
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
44 $9 $41
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
29 $55 $414
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $121 $741
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
73.4% high complexity
21.6% medium
5.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,755
Total received (2018-2024)
Avg $1,394/year across 7 years
Top 22% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
341
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,575 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,731
2023
$1,698
2022
$1,593
2021
$1,241
2020
$662
2019
$1,074
2018
$1,756

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$540
ABBVIE INC.
$432
UCB, Inc.
$372
Novartis Pharmaceuticals Corporation
$97
Janssen Biotech, Inc.
$62
AstraZeneca Pharmaceuticals LP
$46
GENZYME CORPORATION
$38
PFIZER INC.
$36
Sandoz Inc.
$31
E.R. Squibb & Sons, L.L.C.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Fresenius Kabi USA, LLC
$22
Top 3 companies account for 77.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,612
Novartis Pharmaceuticals Corporation
$1,837
UCB, Inc.
$875
ABBVIE INC.
$799
AbbVie Inc.
$694
Horizon Therapeutics plc
$511
Lilly USA, LLC
$440
Genentech USA, Inc.
$340
AbbVie, Inc.
$242
Celgene Corporation
$233
Janssen Biotech, Inc.
$215
AstraZeneca Pharmaceuticals LP
$162
GENZYME CORPORATION
$137
PFIZER INC.
$132
Janssen Scientific Affairs, LLC
$114
Horizon Pharma plc
$104
Bioventus LLC
$89
Sandoz Inc.
$54
E.R. Squibb & Sons, L.L.C.
$47
Fresenius Kabi USA, LLC
$40
Gilead Sciences, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Pacira Therapeutics, Inc.
$17
Top 3 companies account for 54.6% of all-time payments
Associated products mentioned in payments ›
Actemra · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Durolane · EVENITY · Enbrel · GELSYN 3 · GELSYN-3 · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · KEVZARA · KRYSTEXXA · ORENCIA · Otezla · RAYOS · REMICADE · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · TALTZ · TREMFYA · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Springfield?
Compare rheumatologists in the Springfield area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
13
Per 100K population
6.7
County median income
$74,114
Nearest hospital
MEMORIAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Trapp is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Trapp experienced with golimumab infusion (simponi aria)?
Based on Medicare claims data, Dr. Trapp performed 10,000 golimumab infusion (simponi aria) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trapp receive payments from pharmaceutical companies?
Yes. Dr. Trapp received a total of $9,755 from 23 companies across 341 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trapp's costs compare to other rheumatologists in Springfield?
Dr. Trapp's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trapp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →